We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
One More Step to Finalize Your Registration
An activation link has been sent to your email address.
Please check the email and activate your account now. It might take few minutes to get the email.
If you did not find it, please check your spam box.
Having problem receiving the email? Send again
Still cannot receive? Contact us
Email ：PharmaSources@imsinoexpo.com
Whatsapp ：+86-13621645194
Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Monthly Production Capacity: mg to grams
Packaging Information: 10mg,50mg, 100mg,1g,10g
Delivery Lead Time: available in stock
Sample Provided: yes
Payment Terms: T/T
Setmelanotide
Synonyms:RM-493,IRC-022493,BIM-22493
CAS No.: 920014-72-8
Catalog No.:GT-L001
Key Specification:
Appearance: White powder
Purity (HPLC) ≥98.0%
Single impurity≤1.0%
Peptide content≥80.0%
Amino Acid Composition≤±10%
Package:
Vacuum-packed with aluminum foil bag or transparent bag. 10mg,50mg, 100mg,1g,10g, 50g per package with icebag. Or according to your request.
Description:
Setmelanotide is a melanocortin 4 receptor (MC4R) agonist, which acts on human and rat melanocortin 4 receptor. The mechanism of setmelaninide activating MC4R may be different from that of natural ligand and first generation synthetic agonist. Setmelanotide may play a role by antagonizing neurotransmitters that exist naturally and inhibit MC4R activation. It has been proved that setmelanotide has a positive effect on obesity, It has reached the clinical end point of stage 3.
Storage:Cool dry place( Store at -20°C, away from the light)
Audited Supplier
Pharma Sources Insight June 2024: Globalization on the Go
